IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i15p5445-d391179.html
   My bibliography  Save this article

Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research

Author

Listed:
  • Rebecca D. Kehm

    (Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA)

  • Jasmine A. McDonald

    (Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA
    Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, 1130 St Nicholas Ave, New York, NY 10032, USA)

  • Suzanne E. Fenton

    (National Toxicology Program Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, 111 TW Alexander Drive, Durham, NC 27709, USA)

  • Marion Kavanaugh-Lynch

    (California Breast Cancer Research Program, University of California, 300 Lakeside Drive, Oakland, CA 94612, USA)

  • Karling Alice Leung

    (Sapientiae, 1977 Manzanita Dr, Oakland, CA 94611, USA)

  • Katherine E. McKenzie

    (California Breast Cancer Research Program, University of California, 300 Lakeside Drive, Oakland, CA 94612, USA)

  • Jeanne S. Mandelblatt

    (Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Rd. NW, Washington, DC 20057, USA
    These two authors are joint senior authors.)

  • Mary Beth Terry

    (Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA
    Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, 1130 St Nicholas Ave, New York, NY 10032, USA
    These two authors are joint senior authors.)

Abstract

Measuring systemic chronic inflammatory markers in the blood may be one way of understanding the role of inflammation in breast cancer risk, and might provide an intermediate outcome marker in prevention studies. Here, we present the results of a systematic review of prospective epidemiologic studies that examined associations between systemic inflammatory biomarkers measured in blood and breast cancer risk. From 1 January 2014 to 20 April 2020, we identified 18 unique studies (from 16 publications) that examined the association of systemic inflammatory biomarkers measured in blood with breast cancer risk using prospectively collected epidemiologic data. Only one marker, C-reactive protein, was studied extensively (measured in 13 of the 16 publications), and had some evidence of a positive association with breast cancer risk. Evidence associating other inflammatory biomarkers and more comprehensive panels of markers with the development of breast cancer is limited. Future prospective evidence from expanded panels of systemic blood inflammatory biomarkers is needed to establish strong and independent links with breast cancer risk, along with mechanistic studies to understand inflammatory pathways and demonstrate how breast tissue responds to chronic inflammation. This knowledge could ultimately support the development and evaluation of mechanistically driven interventions to reduce inflammation and prevent breast cancer.

Suggested Citation

  • Rebecca D. Kehm & Jasmine A. McDonald & Suzanne E. Fenton & Marion Kavanaugh-Lynch & Karling Alice Leung & Katherine E. McKenzie & Jeanne S. Mandelblatt & Mary Beth Terry, 2020. "Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research," IJERPH, MDPI, vol. 17(15), pages 1-21, July.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:15:p:5445-:d:391179
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/15/5445/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/15/5445/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:15:p:5445-:d:391179. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.